Roundys, FX Allianc...
Health Care: Drugs
Compugen Ltd. (CGEN: NASDAQ)
$5.95 -0.04 | -0.67%
02/09/12 - 03:59 PM ET
90.04K / 83.80K
Vol / Avg. Vol:5.97 / 5.99
Open / Prev. Close:5.82 - 6.01
Today's Range:3.32 - 6.47
52 Wk Range:20.40%
Performance YTD:TheStreet Rating:
Portfolios with CGEN
- Portfolio NameUser Type
- Contributor5 Bargain Biotech Stocks
- Userdesignbydiana Portfolio 1
- Userraveha1 Portfolio 1
- ContributorBiotech Short Squeezes
- UserSUPRATRADE-QUANTUM STARDUST 8
- UserHumelor Portfolio 1
Latest CGEN Headlines from TheStreet
- 5 Bargain Biotech Stocks 01.13.11 | 05:01 pm
- Maguire Properties, Compugen: Midday Volume Plays 05.11.10 | 11:05 am
- eOn Communications, Compugen: Early Volume Plays 03.16.10 | 09:03 am
- Pluristem Therapeutics, Compugen: Early Volume Plays 03.02.10 | 09:03 am
- Array BioPharma, Sterling Financial: Early Volume Plays 02.02.10 | 09:02 am
- Biotech's Movers & Shakers 2009: BioBuzz 01.04.10 | 09:01 am
- Compugen, Flotek: Early Volume Plays 01.04.10 | 07:01 am
- China BAK, Compugen: Early Volume Plays 12.30.09 | 08:12 am
- Compugen, Sinovac: Early Volume Plays 12.28.09 | 08:12 am
- Tuesday's Small-Cap Winners & Losers 06.20.07 | 12:06 am
Press Releases for CGEN
- Compugen Cancer Target Results Demonstrate Significant Potential For Cancer Immunotherapy - Business Wire 02.02.12 | 06:02 am
- Compugen To Broaden And Accelerate Monoclonal Antibody Program For Oncology And Immunology - Business Wire 12.20.11 | 10:12 am
- BioLineRx To Develop And Commercialize Novel Peptide Drug Candidates Discovered By Compugen - Business Wire 12.13.11 | 06:12 am
- Compugen Presents Predictive Drug Target Discovery Platform At European Antibody Conference - Business Wire 11.30.11 | 07:11 am
- Www.discoverx.com - Business Wire 11.29.11 | 07:11 am
- Compugen Reports Third Quarter 2011 Financial Results - Business Wire 11.08.11 | 07:11 am
- Compugen's CGEN-15001 Pre-Clinical Data Presented At International Conference On Immune Tolerance - Business Wire 10.25.11 | 07:10 am
- Compugen Third Quarter 2011 Conference Call Scheduled For Tuesday, November 8, 2011 At 10:00 AM EST - Business Wire 10.24.11 | 07:10 am
- Pulmonary Fibrosis Foundation To Fund Further Therapeutic Evaluation Studies For Compugen-Discovered Drug Candidate - Business Wire 10.12.11 | 08:10 am
- Compugen Announces Validation Of Two Immune System Modulating Drug Candidates - Business Wire 09.13.11 | 07:09 am
Partner Headlines for CGEN
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
- Compugen: On the Road to Breakthroughs - Seeking Alpha 05.12.10 | 03:05 am
